150 mg Caffeine Did Not Trigger Panic Disorder Anxiety

TL;DR: A normal coffee-sized dose of caffeine did not push panic disorder patients into a subjective anxiety surge. It did make their bodies louder, their decisions more avoidant, and their attention more captured by internal sensations — a quieter risk than the old caffeine-panic story.

Source: Journal of Psychopharmacology (2025) | Hoppe et al.

Caffeine has a bad reputation in panic disorder, and there is a real reason for it. At 400 mg or above — the kind of dose used in lab provocation studies — caffeine triggers panic attacks in roughly half of people with panic disorder, while only a small fraction of healthy controls react that way. The clinical leap from those numbers, though, is everything: patients often get told to abstain entirely, even though no one had carefully tested what an ordinary cup of coffee does.

This trial filled in the missing middle. It asked what happens at 150 mg — a dose closer to a strong morning coffee than to a laboratory stress test.

Why the Caffeine-Panic Story Needed an Update

The scary numbers in panic disorder come from high-dose challenges that were never meant to model everyday consumption. They were designed to provoke. And they did.

That worked as proof of mechanism, but it left clinicians with a problem: there was no good evidence about what a moderate dose does in the same patients. So the standard advice defaulted to abstinence, which is easy to give and hard to follow.

Hoppe and colleagues built a study explicitly around the missing dose. Each participant — 29 adults with panic disorder, 53 healthy controls, all low habitual caffeine users — completed two blinded sessions 2 to 14 days apart. One session delivered a 150 mg caffeine capsule after 36 hours without caffeine; the other delivered an identical microcrystalline-cellulose placebo. The within-person design meant each participant served as their own control.

The team measured four different things at once: subjective anxiety, skin conductance during emotional-face viewing, willingness to absorb costs to avoid aversive stimuli, and attentional pull from internal bodily sensations. Each captures a different layer of how caffeine might destabilize someone with panic disorder.

The Panic Result Was Surprisingly Quiet

The primary endpoint cut against the authors’ own hypothesis. Caffeine did not increase subjective anxiety in a way that differed across time or group. Panic disorder patients were more anxious overall than controls, as expected — but 150 mg caffeine did not push them into a unique caffeine-driven spike.

The panic-attack count was the same kind of quiet. Across 82 participants and two sessions each, exactly one panic attack happened. It was a panic disorder patient, after caffeine, during the emotional-reactivity task.

That single attack does not make caffeine irrelevant. It does mean the inferential jump from “high-dose caffeine can provoke panic” to “every panic patient should avoid all coffee” is too blunt for the evidence at this dose.

The Body Reacted Even When Anxiety Did Not

The quiet anxiety result did not mean caffeine did nothing. Skin conductance — the standard physiological readout of arousal — increased under caffeine when participants viewed both neutral and emotional faces. The body was more activated, full stop.

That distinction matters in panic disorder. The cognitive theory of panic argues that attacks begin when a normal jolt of bodily arousal gets misread as danger, and the misreading runs away with itself. The new data suggest that at 150 mg, the extra arousal was usually not enough to trigger that interpretive cascade.

It is the kind of result that should reshape the metaphor. Arousal is not panic. A faster internal signal can be uncomfortable, distracting, even unpleasant — without becoming a full attack.

The Behavioral Shift May Matter More Than the Anxiety Score

The most actionable finding came from the approach-avoidance task. Participants chose between safe options with no reward and riskier options that paid points but came paired with unpleasant images or panic-related sounds. Under caffeine, they were more willing to give up reward to avoid the discomfort.

The effect appeared in both groups, so it is not a panic-disorder-specific vulnerability. But for clinical work, that does not make it harmless.

Exposure therapy — the workhorse of panic treatment — depends on patients approaching feared situations long enough to learn that survival happens. If caffeine nudges that decision toward retreat, a hard exposure assignment becomes harder, even when caffeine is not directly producing panic. The same logic applies to any everyday situation that asks for engagement instead of withdrawal: a job interview, a difficult conversation, a public talk.

The attention finding rhymes with this. Caffeine did not make interoceptive anxiety surge, but bodily sensations interfered more with attention to the external task. For panic disorder, that distinction is clinically real. Patients often struggle less with the arousal itself than with what arousal captures and interrupts.

Translated to a normal day: a moderate caffeine dose may not start a panic attack, but it can make the body louder. A louder body pulls attention inward, makes uncertainty feel more urgent, and tilts decisions toward escape. That is a subtler risk than the textbook caffeine-panic story — and probably closer to what patients actually notice.

Blanket Coffee Bans Look Too Simple

The authors’ practical conclusion is appropriately measured: caffeine-abstinence advice in panic disorder should rest on higher-dose evidence and individual assessment, not a default for everyone.

The caveats matter. The sample was modest, low-caffeine users were intentionally selected, the panic disorder group skewed female, and the trial tested one acute 150 mg dose. It cannot speak to repeated daily caffeine, larger moderate doses, energy drinks, sleep deprivation, or people who already drink several cups a day.

What it can do is reframe the clinical question. The useful one is no longer “is caffeine good or bad for panic disorder.” It is whether caffeine predictably changes a particular patient’s avoidance, attention, sleep, or exposure practice. That is something a clinician and patient can actually track.

For low-habitual-caffeine adults with panic disorder, the headline finding is narrower than the old story but more useful: one 150 mg caffeine dose did not behave like a panic switch. It behaved like a stimulant — raising arousal, tipping decisions toward avoidance, and pulling attention inward — without reliably tipping any of those signals into panic.

That is not reassurance, and it is not alarm. It is the more honest middle that the older caffeine-panic literature could not give patients.